Financial Management Professionals’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.74M Sell
11,025
-975
-8% -$154K 0.16% 48
2026
Q2
$1.9M Buy
12,000
+11,720
+4,186% +$1.58M 0.18% 46
2026
Q1
$35.8K Hold
280
– – ﹤0.01% 298
2025
Q4
$34.1K Hold
280
– – ﹤0.01% 298
2025
Q3
$28.1K Sell
280
-87
-24% -$7.84K ﹤0.01% 327
2025
Q2
$30.4K Sell
367
-605
-62% -$48.3K ﹤0.01% 338
2025
Q1
$78.8K Sell
972
-83
-8% -$7.42K 0.01% 205
2024
Q4
$95K Sell
1,055
-6
-0.6% -$581 0.01% 198
2024
Q3
$105K Hold
1,061
– – 0.01% 191
2024
Q2
$98K Hold
1,061
– – 0.01% 196
2024
Q1
$101K Buy
1,061
+271
+34% +$25.1K 0.01% 198
2023
Q4
$71K Sell
790
-12
-1% -$891 0.01% 221
2023
Q3
$59K Hold
802
– – 0.01% 232
2023
Q2
$67K Sell
802
-949
-54% -$79.4K 0.01% 234
2023
Q1
$133K Buy
1,751
+1,342
+328% +$111K 0.03% 164
2022
Q4
$34K Sell
409
-4
-1% -$324 0.01% 275
2022
Q3
$33K Sell
413
-252
-38% -$21.2K 0.01% 265
2022
Q2
$49K Sell
665
-57
-8% -$4.28K 0.01% 229
2022
Q1
$65K Buy
722
+252
+54% +$23.3K 0.01% 217
2021
Q4
$53K Hold
470
– – 0.01% 246
2021
Q3
$59K Sell
470
-3
-0.6% -$386 0.01% 233
2021
Q2
$64K Buy
473
+4
+0.9% +$526 0.02% 211
2021
Q1
$64K Buy
469
+8
+2% +$1.2K 0.02% 203
2020
Q4
$65K Sell
461
-20
-4% -$2.56K 0.02% 188
2020
Q3
$54K Sell
481
-102
-17% -$11.4K 0.02% 195
2020
Q2
$65K Buy
+583
New +$57.4K 0.02% 164
2018
Q2
– Sell
-35,392
Closed -$3.1M – 312
2018
Q1
$3.1M Buy
35,392
+2,434
+7% +$222K 1.61% 14
2017
Q4
$2.8M Buy
+32,958
New +$2.76M 1.18% 18

Other funds holding XBI

Financial Management Professionals's XBI Position: Q3 2026 in Review

Financial Management Professionals reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 8.1% in Q3 2026, selling an estimated $154K and leaving 11,025 shares worth $1.74M. The position accounts for 0.16% of the portfolio, ranked #48.

Financial Management Professionals first reported a position in XBI in Q4 2017 and has held it in 28 quarters since. The position peaked at $3.1M in Q1 2018. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Financial Management Professionals held 11,025 shares of State Street SPDR S&P Biotech ETF worth $1.74M as of Q3 2026.
  • Financial Management Professionals sold 975 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $154K.
  • State Street SPDR S&P Biotech ETF made up 0.16% of Financial Management Professionals's portfolio in Q3 2026, its #48 holding.
  • Financial Management Professionals first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 28 quarters since.
  • Financial Management Professionals's State Street SPDR S&P Biotech ETF position peaked at $3.1M in Q1 2018.
  • 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Financial Management Professionals's 13F filing for Q3 2026, filed 23 Oct 2026.